Risk Factors of Type 2 Diabetes and Cardiovascular Diseases among Saudi Arabian Adolescents

2016 ◽  
Vol 15 (9) ◽  
pp. 883-888 ◽  
Author(s):  
Baker M. Albow ◽  
Awwad K. Alenezy
2014 ◽  
Vol 66 (1) ◽  
pp. 5-10 ◽  
Author(s):  
K. Umamahesh ◽  
A. Vigneswari ◽  
G. Surya Thejaswi ◽  
K. Satyavani ◽  
Vijay Viswanathan

2021 ◽  
Vol 319 ◽  
pp. 01058
Author(s):  
Otmane El Brini ◽  
Omar Akhouayri ◽  
Bouchra Benazzouz

Background: Metabolic syndrome is a cluster of metabolic risk factors for type 2 diabetes mellitus and cardiovascular diseases. Physiological variations occurring in women during menopause are thought to be a predisposing factor for the metabolic syndrome. The aim of this study was to evaluate the prevalence of metabolic syndrome and its individual components according to menopausal status in a sample of Moroccan women. Methods: We analyzed data of 653 women aged 19 years and older. We used the recently published joint interim statement criteria to classify subjects as having metabolic syndrome. Results: Out of the total subjects, 262 (40.12%) were syndromic. The metabolic syndrome and abdominal obesity were more common in postmenopausal than in premenopausal women. The highest prevalence of metabolic syndrome was observed in menopausal transition especially among women aged 49-52 years (62.59%). During this period, half of women have at least three metabolic syndrome risk factors. Conclusion: Abdominal obesity associated with metabolic changes occurring in menopause was a risk factor for the development of metabolic syndrome in women. There is a need to adopt a healthy lifestyle to prevent weight gain in women. This can minimize the incidence of metabolic syndrome and its consequences as type 2 diabetes and cardiovascular diseases.


2020 ◽  
Vol 34 (10) ◽  
pp. 2706-2711
Author(s):  
Akram Kooshki ◽  
Tahereh Tofighiyan ◽  
Neda Rastgoo ◽  
Mohammad Hassan Rakhshani ◽  
Mohammad Miri

2020 ◽  
Author(s):  
Hanxiao Sun ◽  
Meng Lin ◽  
Emily M. Russell ◽  
Ryan L. Minster ◽  
Tsz Fung Chan ◽  
...  

AbstractEpidemiological studies of obesity, Type-2 diabetes (T2D), cardiovascular diseases and several common cancers have revealed an increased risk in Native Hawaiians compared to European- or Asian-Americans living in the Hawaiian islands. However, there remains a gap in our understanding of the genetic factors that affect the health of Native Hawaiians. To fill this gap, we studied the genetic risk factors at both the chromosomal and sub-chromosomal scales using genome-wide SNP array data on ∼4,000 Native Hawaiians from the Multiethnic Cohort. We estimated the genomic proportion of Native Hawaiian ancestry (“global ancestry,” which we presumed to be Polynesian in origin), as well as this ancestral component along each chromosome (“local ancestry”) and tested their respective association with binary and quantitative cardiometabolic traits. After attempting to adjust for non-genetic covariates evaluated through questionnaires, we found that per 10% increase in global Polynesian genetic ancestry, there is a respective 8.6%, and 11.0% increase in the odds of being diabetic (P = 1.65 10−4) and having heart failure (P = 2.18 10−4), as well as a 0.059 s.d. increase in BMI (P = 1.04 10−10). When testing the association of local Polynesian ancestry with risk of disease or biomarkers, we identified a chr6 region associated with T2D. This association was driven by an uniquely prevalent variant in Polynesian ancestry individuals. However, we could not replicate this finding in an independent Polynesian cohort from Samoa due to the small sample size of the replication cohort. In conclusion, we showed that Polynesian ancestry, which likely capture both genetic and lifestyle risk factors, is associated with an increased risk of obesity, Type-2 diabetes, and heart failure, and that larger cohorts of Polynesian ancestry individuals will be needed to replicate the putative association on chr6 with T2D.Author SummaryNative Hawaiians are one of the fastest growing ethnic minority in the U.S., and exhibit increased risk for metabolic and cardiovascular diseases. However, they are generally understudied, especially from a genetic perspective. To fill this gap, we studied the association of Polynesian genetic ancestry, at genomic and subgenomic scale, with quantitative and binary traits in self-identified Native Hawaiians. We showed that Polynesian ancestry, which likely capture both genetic and non-genetic risk factors related to Native Hawaiian people and culture are associated with increased risk for obesity, type-2 diabetes, and heart failure. While we do not endorse utilizing genetic information to supplant current standards of defining community membership through self-identity or genealogical records, our results suggest future studies could identify population-specific genetic susceptibility factors that may be useful in suggesting underlying biological mechanisms and reducing the disparity in disease interventions in Polynesian populations.


2013 ◽  
Vol 59 (1) ◽  
pp. 3-7
Author(s):  
R M Mamedgasanov ◽  
T V Mekhtiev

Aim of the study. To detect hypogonadism and elucidate its relationship with erectile dysfunction (ED) and the main risk factors of cardiovascular diseases (CVD) among the patients with type 2 diabetes mellitus (DM2). Materials and methods. This clinical epidemiological study included 261 men with DM2 at the age varying from 30 to 59 years. The following exclusion criteria were used: type 1 diabetes mellitus, primary hypogonadism, drug-induced and congenital diseases accompanied by hypogonadism, oncological and cardiovascular diseases. All the patients underwent routine clinical examination, questionnaire and instrumental studies, laboratory analysis including assays for sex hormones. Results. Hypogonadism was diagnosed based on the results of all above studies in 114 (43.7%) men presenting with type 2 diabetes mellitus whereas the AMS questionnaire revealed a 10% higher incidence of age-related hypogonadism (in 141 or 54% subjects). It means that the incidence of hypogonadism increases with age both among the patients with DM2 and in the general male population. For example, only 17.5% of the men at the age of 30-39 years suffered hypogonadism compared with thrice this frequency in the groups of 40-49 and 50-59 year-old subjects. The summarized international erectile function index (IEFI) in the patients with hypogonadism and DM2 was 14.2±0.5 compared with 19.0±0.9 in the group without hypogonadism (p<0.001). Erectile dysfunction was diagnosed in 42 (28.6%) of the 147 patients with DM2 in the absence of hypogonadism whereas all the patients with hypogonadism suffered ED. The groups of the patients presenting with DM2 and hypogonadism and with DM2 without hypogonadism were not significantly different in terms of the number of smokers and hypokinetic subjects (roughly 70%). A similar tendency was documented in the occurrence of such parameters as waist circumference and serum triglycerides levels whereas the total and LDLP cholesterol levels, arterial pressure and body mass index were significantly higher in the patients with hypogonadism. Conclusion. Almost each second man with type 2 diabetes mellitus suffers hypogonadism and the number of such patients increases with age. The presence of DM2 increases the risk of development of ED. Also, the probability of ED and its severity increase under effect of androgen deficiency. The combination of DM2 and hypogonadism promotes manifestation of the main risk factors of cardiovascular diseases.


2013 ◽  
Vol 10 (2) ◽  
pp. 72 ◽  
Author(s):  
Olatunde Odusan ◽  
O Olayemi ◽  
HusseanT Raimi ◽  
JacobO Adenuga ◽  
OlurantiB Familoni

Vestnik ◽  
2021 ◽  
pp. 40-43
Author(s):  
А.М. Барат ◽  
Г.Д. Жаманбай ◽  
Б.Б. Тельман ◽  
А.Б. Кенесхан ◽  
Д.К. Досиханова ◽  
...  

Дефицит витамина D, а также сердечно-сосудистые заболевания (ССЗ) и связанные с ними факторы риска широко распространены во всем мире и часто возникают одновременно. Давно известно, что витамин D является неотъемлемой частью метаболизма костей, хотя недавние данные свидетельствуют о том, что витамин D играет ключевую роль в патофизиологии других заболеваний, включая сердечно-сосудистые заболевания. В этом обзоре мы стремимся обобщить самые последние данные об участии дефицита витамина D в развитии основных факторов риска сердечно-сосудистых заболеваний: артериальной гипертензии, ожирения и дислипидемии, диабета 2 типа, хронического заболевания почек и эндотелиальной дисфункции. Кроме того, мы приводим самые последние данные наблюдений, а также интервенционные данные о влиянии витамина D на сердечно-сосудистые заболевания. Vitamin D deficiency, as well as cardiovascular disease (CVD) and associated risk factors, are widespread throughout the world and often occur concurrently. Vitamin D has long been known to be an essential part of bone metabolism, although recent evidence suggests that vitamin D plays a key role in the pathophysiology of other diseases, including cardiovascular disease. In this review, we seek to summarize the most recent evidence on the involvement of vitamin D deficiency in the major risk factors for cardiovascular disease: hypertension, obesity and dyslipidemia, type 2 diabetes, chronic kidney disease, and endothelial dysfunction. In addition, we provide the most recent observational data as well as interventional evidence on the effects of vitamin D on cardiovascular disease.


Sign in / Sign up

Export Citation Format

Share Document